Anti-interleukin-2 receptor monoclonal antibody 33B3-1

Drug Profile

Anti-interleukin-2 receptor monoclonal antibody 33B3-1

Alternative Names: 33B3.1; Anti-CD25 monoclonal antibody 33B3.1; Interleukin-2 receptor monoclonal antibody 33B3.1

Latest Information Update: 05 Jul 1999

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Immunotech
  • Developer Immunotech; Nonindustrial source; sanofi pasteur
  • Class Monoclonal antibodies
  • Mechanism of Action Interleukin 2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Transplant rejection

Most Recent Events

  • 05 Jul 1999 No-Development-Reported for Transplant rejection in France (IV-infusion)
  • 18 Mar 1996 New profile
  • 18 Mar 1996 Phase-II clinical trials for Transplant rejection in France (IV-infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top